Citadel Advisors’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Hold |
|
|||||
|
2023
Q2 | – | Hold |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $9.26K | Sell |
|
|||||
|
2022
Q3 | $87K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $86K | Sell |
|
|||||
|
2021
Q4 | $378K | Buy |
|
|||||
|
2021
Q3 | $330K | Sell |
|
|||||
|
2021
Q2 | $442K | Sell |
|
|||||
|
2021
Q1 | $985K | Buy |
|
|||||
|
2020
Q4 | $106K | Buy |
|
|||||
|
2020
Q3 | $95K | Buy |
|
|||||
|
2020
Q2 | $36K | Sell |
|
|||||
|
2020
Q1 | $63K | Buy |
|
|||||
|
2019
Q4 | $61K | Buy |
|
|||||
|
2019
Q3 | – | Hold |
|
|||||
|
2019
Q2 | – | Hold |
|
|||||
|
2019
Q1 | – | Hold |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $198K | Buy |
|
|||||
|
2018
Q2 | – | Hold |
|
|||||
|
2018
Q1 | – | Hold |
|
|||||
|
2017
Q4 | – | Hold |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $7.78M | Buy |
|
|||||
|
2017
Q1 | $6.77M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $218K | Buy |
|